Icosavax
Icosavax is a Washington-based biotechnology company that develops and commercializes VLP vaccines for the treatment of respiratory diseases.
Business Model:
Revenue: $2.7M
Employees: 11-50
Industries / Tags:
Detailed Icosavax Information
Geographic Data
Address: 1616 Eastlake Avenue E.
City: Seattle
State: WA
Zip: 98102
Country: US
Financial Info
Stage:
series b
Raised Last:
$100M
Raised Total:$161M
Social
Metrics
4,817,520Website Global Rank
1,782Website Monthly Traffic
Twitter Followers
Description
Icosavax is a Washington-based biotechnology company that develops and commercializes VLP vaccines for the treatment of respiratory diseases.
Contact Phone:
+12063365600
Contact Email:
Icosavax went public on 7/29/2021 on the NASDAQ
Listed Exchange:
NASDAQ
IPO Date:
7/29/2021
IPO Valuation:
$563M
Ticker Symbol:
ICVX
IPO Price:
$15/share
Amount Raised:
$182M
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|
| Announced Date | Name | Price |
|---|
Employee Departments
Employee States
|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|
